Currently, there are 138.76M common shares owned by the public and among those 138.69M shares have been available to trade.
The company’s stock has a 5-day price change of 32.61% and 154.17% over the past three months. LX shares are trading 132.07% year to date (YTD), with the 12-month market performance up to 123.56% higher. It has a 12-month low price of $1.56 and touched a high of $4.70 over the same period. LX has an average intraday trading volume of 3.79 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 24.95%, 38.75%, and 103.96% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of LexinFintech Holdings Ltd ADR (NASDAQ: LX) shares accounts for 24.25% of the company’s 138.76M shares outstanding.
It has a market capitalization of $592.51M and a beta (3y monthly) value of 0.56. The stock’s trailing 12-month PE ratio is 6.87, while the earnings-per-share (ttm) stands at $0.62. The company has a PEG of 2.91 and the debt-to-equity ratio at 0.44. Price movements for the stock have been influenced by the stock’s volatility, which stands at 10.42% over the week and 8.10% over the month.
Earnings per share for the fiscal year are expected to increase by 88.47%, and 35.61% over the next financial year. EPS should grow at an annualized rate of 2.36% over the next five years, compared to -13.91% over the past 5-year period.
CLSA was of a view on March 16, 2023 that the stock is Buy, while Citigroup gave the stock Buy rating on March 14, 2023, issuing a price target of $2.31- $3.60. UBS on their part issued Buy rating on February 01, 2023.
